Hong Kong stock unusual movement | Cornerstone Pharmaceuticals-B (02616.HK) rose more than 5% Multiple directors have significantly increased their holdings since June, CS5007 global clinical development fully launched

Zhixin Finance APP learned that Cornerstone Pharmaceuticals-B (02616.HK) rose more than 5%, and as of the time of publication, it had risen by 4.39% to 4.76 Hong Kong dollars, with a trading volume of 10.61 million Hong Kong dollars.